SciClone Pharmaceuticals Inc. (SCLN) announced that it has appointed Hong Zhao as its Chief Executive Officer, China Operations. Zhao has more than 20 years of experience in leading the commercial operations, market expansion and growth of multi-national companies in China.
Zhao joins SciClone from Simcere Pharmaceutical Group, where he served as Executive Vice President, responsible for all business operations. Prior to Simcere, he held positions of increasing seniority at Novartis China, from Regional Sales Manager, National Sales Director, Vice President, Senior Vice President of Novartis Greater China and General Manager of Novartis Shanghai.
Zhao also served with Xi'an Janssen Pharmaceutical, where he rose quickly from Medical Representative to District Sales Manager. Earlier in his career he served as a lecturer and tutor at Nanjing Medical College.
For comments and feedback: editorial@rttnews.com